| Issue Date | Title | Author(s) |
| 2022-01-01 | Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial. | Felker, GM; Solomon, SD; Claggett, B; Diaz, R; McMurray, JJV; Metra, M; Anand, I; Crespo-Leiro, MG; Dahlström, U; Goncalvesova, E; Howlett, JG; MacDonald, P; Parkhomenko, A; Tomcsányi, J; Abbasi, SA; Heitner, SB; Hucko, T; Kupfer, S; Malik, FI; Teerlink, JR |
| 2021-04-01 | Baseline Gas Transfer (KCO) and Accessible Alveolar Volume (VA) after Lung Transplant: Determinants and Relative Contributions on Graft Survival | Darley, DR; Malouf, MA; MacDonald, P; Plit, M |
| 2020-09-27 | Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort. | Withers, B; McCaughan, G; Hayward, C; Kotlyar, E; Jabbour, A; Rainer, S; De Angelis, E; Horvath, N; Milliken, S; Dogan, A; MacDonald, P; Moore, J |
| 2007-01-01 | Cultural diversity in heart failure management: Findings from the DISCOVER study (part 2) | Davidson, PM; MacDonald, P; Moser, DK; Ang, E; Paull, G; Choucair, S; Daly, J; Gholizadeh, L; Dracup, K |
| 2018-01-01 | Frailty Predicts Mortality After Heart Transplantation | Offen, S; Jha, S; Connellan, M; Dhital, K; Granger, E; Harkness, M; Hayward, C; Jabbour, A; Jansz, P; Kotlyar, E; Montgomery, E; Muthiah, K; Spratt, P; MacDonald, P |
| 2012-10-02 | Impact of home versus clinic-based management of chronic heart failure: The WHICH? (Which heart failure intervention is most cost-effective & consumer friendly in reducing hospital care) multicenter, randomized trial | Stewart, S; Carrington, MJ; Marwick, TH; Davidson, PM; MacDonald, P; Horowitz, JD; Krum, H; Newton, PJ; Reid, C; Chan, YK; Scuffham, PA |
| 2023-06 | Pre-operative pulmonary artery pulsatility index does not predict mortality post-cardiac transplantation. | Bart, N; Hungerford, S; Emmanuel, S; Kotlyar, E; Keogh, A; MacDonald, P; Muller, D; Hayward, C |
| 2018-07-01 | Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization | Keir, GJ; Wort, SJ; Kokosi, M; George, PM; Walsh, SLF; Jacob, J; Price, L; Bax, S; Renzoni, EA; Maher, TM; MacDonald, P; Hansell, DM; Wells, AU |
| 2021-04-01 | Release the Pressure! Does Jugular Venous Pressure Predict Rejection in Cardiac Biopsy? | Deveza e Silva, RCC; Schnegg, B; Gorrie, N; Koppe, F; Lee, I; Hayward, C; MacDonald, P |
| 2021-12 | Swallowing and laryngeal complications in lung and heart transplantation: Etiologies and diagnosis. | Black, RJ; Novakovic, D; Plit, M; Miles, A; MacDonald, P; Madill, C |
| 2023-09 | The American Association for Thoracic Surgery 2023 Expert Consensus Document: Adult cardiac transplantation utilizing donors after circulatory death. | Schroder, JN; Scheuer, S; Catarino, P; Caplan, A; Silvestry, SC; Jeevanandam, V; Large, S; Shah, A; MacDonald, P; Slaughter, MS; Naka, Y; Milano, CA |
| 2019-05 | Transfer of donor anti-HLA antibody expression to multiple transplant recipients: A potential variant of the passenger lymphocyte syndrome? | Kummrow, M; Hiho, S; Hudson, F; Cantwell, L; Mulley, WR; D'Orsogna, L; Testro, A; Pavlovic, J; MacDonald, P; Sullivan, LC; Snell, GI; Westall, GP |
| 2013-04-05 | What is the methodological and reporting quality of health related quality of life in chronic heart failure clinical trials? | Chang, S; Davidson, PM; Newton, PJ; Krum, H; Salamonson, Y; MacDonald, P |
| 2011-08-01 | The WHICH? Trial: Rationale and design of a pragmatic randomized, multicentre comparison of home- vs. clinic-based management of chronic heart failure patients | Stewart, S; Carrington, MJ; Marwick, T; Davidson, PM; MacDonald, P; Horowitz, J; Krum, H; Newton, PJ; Reid, C; Scuffham, PA |
